Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd. (HUMDF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
humdf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hua Medicine (Shanghai) Ltd. (HUMDF) measures how much investors pay for each dollar of the company's trailing earnings. HUMDF's current PE ratio of 1.88x is calculated by dividing its stock price of $0.43 by its TTM earnings per share of $1.05. −28.5% discount vs 5Y avg 2.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hua Medicine (Shanghai) Ltd.You HUMDF | $431M | 1.88x | -93.5% | $1.05 |
 Allergy Therapeutics plc AGYTF | $655M | N/A | — | -$0.01 |
 Boiron S.A. BOIRF | $554M | 42.15x | +45.9% | $0.65 |
 Clinuvel Pharmaceuticals Limited CLVLY | $328M | 14.30x | -50.5% | $0.72 |
 Cresco Labs Inc. CRLBF | $333M | N/A | — | -$0.42 |
 Hansa Biopharma AB (publ) HNSBF | $246M | N/A | — | -$6.58 |
 Ion Beam Applications S.A. IOBCF | $550M | 30.22x | +4.6% | $0.43 |
Industry Average 3 peers with valid PE | — | 28.89x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 2.63x | $1.09 | — | |
2024-12-31 FY2024 | — | $-0.25 | — | |
2023-12-31 FY2023 | — | $-0.22 | — | |
2022-12-31 FY2022 | — | $-0.21 | — | |
2021-12-31 FY2021 | — | $-0.35 | — | |
2020-12-31 FY2020 | — | $-0.42 | — | |
2019-12-31 FY2019 | — | $-0.45 | — | |
2018-12-31 FY2018 | — | $-10.07 | — | |
2017-12-31 FY2017 | — | $-0.26 | — | |
2016-12-31 FY2016 | — | $-0.34 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hua Medicine (Shanghai) Ltd. (HUMDF) measures how much investors pay for each dollar of the company's trailing earnings. HUMDF's current PE ratio of 1.88x is calculated by dividing its stock price of $0.43 by its TTM earnings per share of $1.05.
Frequently asked questions
HUMDF pe ratio · 6 questionsHUMDF's current PE ratio is 1.88x as of 2026-06-09, based on a stock price of $0.43 and TTM EPS of $1.05. Data sourced from Financial Modeling Prep via HUMDF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hua Medicine (Shanghai) Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09